A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection

Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) was first identified in 2012, and it continues to threaten human health worldwide. No MERS vaccines are licensed for human use, reinforcing the urgency to develop safe and efficacious vaccines to prevent MERS. MERS-CoV spike protein form...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Virology
Главные авторы: Tai, Wanbo, Zhao, Guangyu, Sun, Shihun, Guo, Yan, Wang, Yufei, Tao, Xinrong, Tseng, Chien-Te K., Li, Fang, Jiang, Shibo, Du, Lanying, Zhou, Yusen
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier Inc. 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5167628/
https://ncbi.nlm.nih.gov/pubmed/27750111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2016.10.005
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы